Detalhe da pesquisa
1.
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Br J Haematol
; 200(6): 731-739, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541117
2.
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
Acta Oncol
; 62(7): 744-752, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039661
3.
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
N Engl J Med
; 373(26): 2499-511, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26699166
4.
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
BMC Cancer
; 17(1): 112, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173773
5.
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.
Blood
; 124(3): 319-27; quiz 466, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740811
6.
Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.
Br J Haematol
; 186(4): e103-e108, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090916
7.
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
J Cancer Surviv
; 2022 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441393
8.
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
N Engl J Med
; 357(19): 1916-27, 2007 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-17989384
9.
Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials.
Haematologica
; 94(12): 1691-7, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19850901
10.
Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology.
Cell Oncol
; 30(1): 27-38, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18219108
11.
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
N Engl J Med
; 348(24): 2396-406, 2003 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-12802025
12.
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Int J Radiat Oncol Biol Phys
; 67(1): 19-30, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097834
13.
The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma.
Haematologica
; 92(2): 184-90, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17296567
14.
ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.
Eur J Cancer
; 81: 45-55, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28601705
15.
Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
Curr Opin Oncol
; 18(6): 660-6, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16988591
16.
Increased vascularization predicts favorable outcome in follicular lymphoma.
Clin Cancer Res
; 11(1): 154-61, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15671540
17.
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group.
Leuk Lymphoma
; 57(5): 1067-73, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26693800
18.
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Int J Radiat Oncol Biol Phys
; 63(4): 1184-90, 2005 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15936157
19.
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
Clin Lymphoma Myeloma
; 6(2): 122-30, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16231850
20.
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Clin Cancer Res
; 9(10 Pt 2): 3995S-4002S, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14506199